PRESS-RELEASE ·Filed Jun 4, 2026

SCLX

Scilex Holding Company
NEUTRAL
Impact 4/10
Horizondays Processed4mo ago WireGlobeNewswire
Press release: dividend
Actionable Insight • Neutral

The dividend provides a direct stake in Semnur, which holds the SEMDEXA (SP-102) asset. Monitor for any board revocation or changes to the payment date. The ex-dividend date set by Nasdaq will determine the trading adjustment for SCLX shares.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
SCLX ▲ +15.05% at T+60d
NEUTRAL call ✓ call won +15.05% · α vs SPY +13.17% · entry $4.72 → $5.43
Entry anchored
Jun 3, 03:58 PM ET
via exchange tick
T+1d
-7.65%
call -7.65% · α -5.07%
$4.36
settled 4mo ago
T+5d
+14.78%
call +14.78% · α +17.33%
$5.42
settled 4mo ago
T+20d
+65.47%
call +65.47% · α +66.85%
$7.81
settled 3mo ago
T+60d
+15.05%
call +15.05% · α +13.17%
$5.43
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Scilex announced a June 15, 2026 payment date for its previously declared dividend of Semnur Pharmaceuticals (OTC: SMNR) common stock, distributing approximately 14 million shares to holders of record as of June 1, 2026. The dividend is subject to board revocation and provides a direct distribution of a key subsidiary's stock to Scilex shareholders.

Key Facts

  • Payment date set for June 15, 2026; record date is June 1, 2026.
  • One share of Semnur common stock per share of Scilex common stock held.
  • Approximately 14 million Semnur shares to be distributed out of 186 million beneficially owned by Scilex.
  • Dividend is conditioned on board not revoking it prior to payment date.
  • Board retains right to change record date and payment date at any time.

Financial Impact

Distribution of ~14 million shares of Semnur common stock; Scilex retains ~172 million shares post-dividend.

share countownership structure

Risk Factors

  • Board may revoke or modify the dividend at any time before payment.
  • Semnur (OTC: SMNR) may have limited liquidity, affecting the value of distributed shares.
  • Scilex retains majority ownership of Semnur, so the dividend does not fully separate the entities.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3306806
11 reports for SCLX
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +36.82%Jun 12, 2026
Filters
Rows
Reports for SCLX — sortable, filterable
TypeNow
Jul 22, 2026
10w ago
8-K
MIXED ★ 5/10
$7.39 $5.80▼ −21.52%▼ −24.82%$4.06 (−45.06%)
Jul 6, 2026
12w ago
8-K
MIXED ★ 6/10
$8.07 $6.67▼ −17.41%▼ −16.84%$4.06 (−49.69%)
Jun 29, 2026
13w ago
8-K
BEARISH ★ 7/10
$7.80 $7.03▲ +9.87%▲ +8.84%$4.06 (+47.95%)
Jun 12, 2026
16w ago
Press Release
NEUTRAL ★ 2/10
$8.50 $9.48▲ +11.53%▲ +9.75%$4.06 (−52.24%)
Jun 12, 2026
16w ago
EFFECT
BEARISH ★ 6/10
$8.50 $9.48▼ −11.53%▼ −9.75%$4.06 (+52.24%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 2/10
$8.70 $9.20▲ +5.75%▲ +3.86%$4.06 (−53.33%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 4/10
$4.72 $7.81▲ +65.47%▲ +66.85%$4.06 (−13.98%)
May 5, 2026
21w ago
Press Release
BULLISH ★ 8/10
$6.68 $4.46▼ −33.18%▼ −37.39%$4.06 (−39.23%)
May 4, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$6.94 $4.61▼ −33.63%▼ −39.42%$4.06 (−41.52%)
Apr 17, 2026
24w ago
Insider Cluster
MIXED ★ 6/10
$4.30 $3.92▼ −8.84%▼ −12.93%$4.06 (−5.50%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (56h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 4, 2026